Randomized Clinical Trial for Comparison Of Intravenous Carbeitocin Versus Oxytocin In Management Of Placental Delivery In Second Trimester Interruption

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01827124

Enrollment

140

Registered

2013-04-09

Start date

2013-04-30

Completion date

2013-12-31

Last updated

2013-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CARBETOCIN FOR PREVENTION OF PLACENTAL RETAINED

Keywords

CARBETOCIN AND OXYTOCIN AND SECOND TRIMESTER INTERRUPTION

Brief summary

Intravenous Carbetocin is more efficient than intravenous infusion oxytocin in management of placental delivery in 2nd trimester interruption.

Interventions

DRUGCarbetocin

DRUGoxytocin

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

PREVENTION

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

FEMALE

Age

16 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Age:16-50 years * Pregnancy duration: 14-24weeks * Spontaneous abortion or medical induced abortion at 14-24weeks

Exclusion criteria

* Age less than 16years and more than 50 years * Surgical termination * Placenta previa * Uterine fibroid

Design outcomes

Primary

Measure	Time frame
Record duration of spontaneous placental expulsion after delivery of fetus in second trimester interruption	at the time of delivery

Secondary

Measure	Time frame
Estimation of blood loss in each group by weighing all pads put under the patient after delivery of fetus tell expulsion of placenta( before and after using of pads).	at time of delivery

Countries

Egypt

Contacts

Primary ContactWAFAA UTHMAN AHMED, M.B.CH.B

WAFAA.UTHMAN@YAHOO.COM00201119760754

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026